Artificial liver support at present and in the future.

Area of Science:

• Hepatology
• Transplantation Medicine
• Biomedical Engineering

Background:

• Liver failure is a critical condition with limited treatment options.
• Donor organ shortages impede liver transplantation globally.
• Japan faces unique cultural and healthcare system challenges regarding liver transplantation.

Purpose of the Study:

• To explore alternative and effective treatments for end-stage liver disease in Japan.
• To evaluate the role of plasma exchange and continuous hemodiafiltration in managing liver failure.
• To discuss the future potential of artificial liver support, gene therapy, and regenerative medicine.

Main Methods:

• Review of current treatment approaches for liver failure in Japan.
• Discussion of the efficacy of plasma exchange (PE) and continuous hemodiafiltration (CHDF).
• Consideration of bioartificial liver support as a secondary treatment option.

Main Results:

• Plasma exchange (PE) and continuous hemodiafiltration (CHDF) are considered highly effective for liver failure treatment.
• These methods are proposed as the primary therapeutic strategy.
• Bioartificial liver support is suggested as a subsequent treatment line.

Conclusions:

• Plasma exchange (PE) and continuous hemodiafiltration (CHDF) represent a viable first-line approach for liver failure.
• Further randomized controlled studies are necessary to validate the efficacy of PE and CHDF.
• Future advancements in gene therapy and regenerative medicine may lead to functional artificial livers.